Follow The Filings

IR Ingersoll Rand

Industrials, filed as INGERSOLL RAND INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 0.9%
  • $98M
  • 2 add

In 2026 Q2 Sarah Ketterer and Wallace Weitz added to Ingersoll Rand.

Who owns this now

Largest portfolio weights among holders, up to 0.9% (Sarah Ketterer, Causeway Capital Management). Not free-float ownership.

  1. Sarah Ketterer Add 0.92%
  2. Wallace Weitz Add 0.92%

Who owns IR

Sorted by value, long equity only, as of 2026 Q2.

History
Sarah Ketterer, Causeway Capital Management 0.92%, was 0.62% Add +65.1% 1,033,693 $85M History
Wallace Weitz, Weitz Investment Management 0.92%, was 0.75% Add +21.4% 161,670 $13M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by IR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IR insider trades
  • $1M bought by 1 insider
  • $9.9M sold by 6 insiders outside a trading plan
  • $49.7M sold by 1 insider under 10b5-1 plans
  1. Aurobind Satpathy Director
    Buy
    $1M 11,538 shares at $86.68 New stake
    Traded Aug 3 Filed Aug 5
    ↗
  2. Vicente Reynal See Remarks
    Planned sale
    $2.7M 30,492 shares at $88.00 13% of stake
    Traded Apr 13 Filed Apr 15
    ↗
  3. Vicente Reynal See Remarks
    Planned sale
    $11.1M 118,044 shares at $94.11 36% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  4. John Humphrey Director
    Sale
    $412K 4,300 shares at $95.90 15% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  5. Vikram Kini CFO
    Sale
    $2.7M 28,367 shares at $96.50 22% of stake
    Traded Feb 20 Filed Feb 23
    ↗
  6. Vicente Reynal See Remarks
    Planned sale
    $90K 900 shares at $100.00 0.5% of stake
    Traded Feb 18 Filed Feb 20
    ↗
  7. Michael J Scheske VP, Chief Accounting Officer
    Sale
    $1.9M 19,122 shares at $97.67 61% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  8. Elizabeth Meloy Hepding See Remarks
    Sale
    $1.8M 18,246 shares at $97.11 53% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  9. Kathleen M. Keene See Remarks
    Sale
    $1.2M 12,000 shares at $99.46 77% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  10. Andrew R Schiesl See Remarks
    Sale
    $1.8M 18,000 shares at $98.00 61% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  11. Vicente Reynal See Remarks
    Planned sale
    $9.2M 92,352 shares at $99.25 32% of stake
    Traded Feb 13–17 Filed Feb 18
    ↗
  12. Vicente Reynal See Remarks
    Planned sale
    $44K 440 shares at $100.00 0.2% of stake
    Traded Feb 11 Filed Feb 13
    ↗
  13. Vicente Reynal See Remarks
    Planned sale
    $9.8M 100,000 shares at $97.54 34% of stake
    Traded Feb 3–4 Filed Feb 5
    ↗
  14. Vicente Reynal See Remarks
    Planned sale
    $16.8M 191,000 shares at $88.12 50% of stake
    Traded Jan 16 Filed Jan 21
    ↗
  15. Michael J Scheske VP, Chief Accounting Officer
    Sale
    $119K 1,477 shares at $80.63 11% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 59 option exercises, 43 share withholdings for taxes, and 6 stock grants.

Congress

5 members of Congress traded IR in the last three years: 5 buys and 5 sales. 6 members listed it in 2025 annual reports.

All Congress trades
  1. Julia Letlow R-LA-5 Sell $1K–$15K Jan 31, 2025 filed Jan 13
  2. Julia Letlow R-LA-5 Buy $1K–$15K Oct 23, 2024 filed Jan 13
  3. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K May 21, 2025 filed Sep 12, 2025
  4. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025
  5. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 13, 2025 filed Jun 6, 2025
  6. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Apr 8, 2025 filed May 8, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 23 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.88B $7.24B $7.65B
Gross profit $2.88B $3.17B $3.34B
Gross margin * 41.9% 43.8% 43.6%
Net income $778.7M $838.6M $581.4M
Net margin * 11.3% 11.6% 7.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.05B $4.16B $4.25B
Total non-current assets * $11.51B $13.85B $14.05B
Total assets $15.56B $18.01B $18.3B
Total current liabilities $1.83B $1.82B $2.07B
Total non-current liabilities * $3.89B $5.95B $6.08B
Total equity $9.78B $10.18B $10.09B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations — — $1.36B
Cash from investing — — -$660.6M
Cash from financing -$0.338B $1.71B -$1.05B
Net change in cash -$17.5M -$54.3M -$292.4M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.